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A commentary on
The impact of neuroimmune alterations in autism spectrum disorder
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The dramatic increasing prevalence of autism spectrum disorders (ASDs) (1), together with the
influence on the quality of life and the lifetime societal cost of caring, has called for newest
research on both the development of these diseases and the therapeutic options. Nowadays, it is well
recognized that multifactorial and polygenic features (complex combination of genetic, epigenetic,
and environmental interactions) characterize ASDs (2). Prenatal immune alterations and early
inflammatory processes could be the autism etiological events. The authors Gottfried et al. (3) in this
hypothesis-and-theory article discuss the recent findings in autism discovery. Starting from a brief
historical way on autism development, the main topic of the article is to focus on the state-of-the-art
of the novel findings in autism studies. The authors rightly highlight the newest challenging frontier
of autism research: the neuroimmune axis alterations. These alterations are first evident in the cells
early responsible for immune responses, as they are the precursors for macrophages, dendritic, and
microglial cells:monocytes or peripheral bloodmononuclear cells (PBMCs). These cells show strong
dysfunctions in ASD children and are committed to a pro-inflammatory state, which in turn result
in long-term immune alterations (4). In ASDs, altered PBMCs are responsible for elevated pro-
inflammatory cytokine production. The up-regulation of inflammatory cytokines is also reflected in
brain centers of autistic patients (5): the consequences are the induction of blood–brain barrier (the
immunological interface between peripheral immune system and central nervous system) disrup-
tion. Changes in BBB permeability directly influence neural plasticity, connectivity and function,
triggering impairments in social interaction, communication, and behavior (3). Immunological
abnormalities also influence the gastrointestinal system and the microglial innate immune cells of
the central nervous system (6). The authors also discuss the role of autoimmunity in the pathogenesis
of autism. Familial or virus/bacteria-infected autoimmunity could be a risk factor for autism.
Even if the exact cellular and molecular pathways responsible for the induction of neuroimmune
alterations are still to be further clarify, a complex interaction among epigenetic and environmental
risk factors (7) could trigger the neuroimmune abnormalities, such as abnormal neuron and glia
responses.
Taken together, these autism-associated neuroimmune changes could help in identifying novel
therapeutic target for a better future management of ASDs.
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